Treventis

For toxic amyloid, the point of contact with a neuron may matter as much as the plaque.

Scientists recently found short, receptor-bound amyloid-beta filaments in Alzheimer’s brain tissue that were about ten times more abundant than free amyloid-beta. These 65-nanometer structures attached to prion protein through their tips and triggered synapse loss in human neurons. Cryo-electron microscopy revealed an architecture resembling longer plaque filaments, with differences in subunit tilt, amino-terminal conformation, length, and seeding behavior. The results challenge the idea that the relevant receptor-bound species must have a separate oligomeric structure. They also sharpen the distinction between plaque accumulation and amyloid interactions that disrupt neuronal connections. This may help guide studies of how amyloid damages synapses. Receptor-bound filaments offer a target for further investigation, but these experiments do not establish an effective treatment in patients.

Visit us at https://treventis.com/


https://www.nature.com/articles/s41467-026-75895-9

A job spent finding the next turn may offer clues about cognitive resilience.

Researchers recently found that taxi and ambulance drivers had the lowest adjusted proportions of Alzheimer’s-attributed deaths among 443 occupations. Across nearly nine million US death records from 2020–2022, Alzheimer’s appeared in 1.03% of taxi-driver deaths and 0.74% of ambulance-driver deaths, versus 3.88% overall. The pattern was absent in transportation jobs involving less real-time navigation and did not extend to other dementias. This raises the possibility that spatial processing relates to brain resilience, but the study cannot show that navigating streets prevents Alzheimer’s. Differences in occupational selection, health, and death-certificate reporting could influence the results. The findings justify investigation of spatial demands and brain health, including whether navigation training benefits cognition.

Future studies should test this link directly.

Visit us at https://treventis.com/


https://www.bmj.com/content/387/bmj-2024-082194

The brain’s immune cells may be stealing daily sleep in an Alzheimer’s mouse model.

Scientists recently found that amyloid plaques in APP/PS1 mice reduced non-REM sleep and disrupted brain-network coordination. Microglia expanded beyond plaque-bearing regions into circuits involved in sleep regulation, with increased cortical excitability. Removing these cells restored more than two hours of sleep daily without reducing amyloid burden, thus supporting their role in driving sleep loss in this model. Additionally, more plaques did not mean less non-REM sleep, whereas aging separately reduced REM sleep and the rebound after sleep deprivation. These differences could help distinguish disease-related changes from normal aging.

The findings support studying microglial activity, sleep patterns, and EEG signals as potential targets or markers; however, neither a human treatment benefit nor a validated early diagnostic test was established, necessitating the need for further human studies.

Visit us at https://treventis.com/


https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.71579

Amyloid plaques may tell only part of the story of failing brain connections. Scientists recently found that aging “Dutch” mice accumulated non-fibrillar amyloid-beta aggregates alongside learning and synaptic deficits.

Nerve terminals showed impaired signal strengthening, greater fatigue, disrupted vesicle replenishment, and reduced mitochondrial complex I activity. Excitatory neurons also showed gene-expression changes involving protein production and energy metabolism. Although classic inflammatory activation was not detected, complement C1q at synapses suggested immune involvement in their removal. The results connect amyloid aggregates with impaired neuronal energy supply and communication, even without widespread detectable inflammation.

Although human confirmation is needed, these mouse findings suggest that plaque removal alone may leave other toxic amyloid forms unaddressed, supporting research into treatments that also protect synapses and restore neuronal energy metabolism.

Visit us at https://treventis.com/


https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.71426

Parkinson’s disease (PD) can arise from various inherited mutations; however, a recent study suggests that these diverse genetic causes may converge on a smaller set of shared cellular failures.

Researchers built 24 genetically controlled Drosophila models of familial PD and related monogenic Parkinsonism, then used unbiased behavioral screening and machine learning to group mutants by functional patterns. Two major clusters emerged: one linked to mitochondrial dysfunction and another tied to retromer and vesicle trafficking, proteostasis, and autophagy. Genes within each cluster showed similar genetic interaction profiles, and pathway-targeted compounds improved dopaminergic neuron dysfunction in a cluster-specific manner.

These findings suggest that familial Parkinsonism may be organized into broader biologic subtypes, which could potentially guide future biomarker discovery as well as more targeted therapeutic strategies.

Visit us at https://treventis.com/


https://www.nature.com/articles/s41467-026-70303-8

The connection between obesity and Alzheimer’s disease may begin long before cognitive symptoms appear.

A recent review traces how shared metabolic stress could link systemic disease to neurodegeneration. Researchers examined overlapping pathways, including adipose-brain signaling via adipokines and extracellular vesicles, disrupted lipid metabolism, insulin resistance, impaired glycolysis, mitochondrial dysfunction, and gut microbiota dysbiosis. Across these mechanisms, mitochondrial impairment emerged as a central link, tying metabolic imbalance to oxidative stress, inflammation, amyloid precursor protein processing, and tau hyperphosphorylation. The review also suggests that some metabolic shifts may precede clinical symptoms, making them relevant to biomarker research.

Together, these findings position metabolism, mitochondrial function, and the gut-brain axis as early biological signals and potential targets for protecting brain health.

Visit us at https://treventis.com/


https://www.mdpi.com/2073-4409/15/8/672

Diabetes is not a uniform risk factor for dementia, and a large Korean cohort has helped to clarify who may be most vulnerable.

Researchers recently analyzed more than 1.3 million adults aged 40 years or older without prior dementia, comparing those without diabetes with those with type 2 diabetes treated with oral agents, type 2 diabetes treated with insulin, or type 1 diabetes. Dementia incidence increased across categories, with the highest rates in type 1 diabetes and insulin-treated type 2 diabetes. After adjusting for demographic, lifestyle, and clinical factors, all diabetes groups had higher risks of all-cause dementia, Alzheimer’s disease, and vascular dementia than individuals without diabetes. The similar risk in type 1 diabetes and insulin-treated type 2 diabetes suggests that insulin-requiring disease may mark a high-risk cognitive phenotype, supporting closer cognitive surveillance and optimized glycemic management.

Visit us at https://treventis.com/


https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1111/dom.70677

Amyloid precursor protein (APP) is often viewed in terms of amyloid-β, but new data are shifting attention to what full-length APP may normally do in cells.

Researchers examined cultured cells, mouse models, and human Alzheimer’s disease (AD) brain tissue to test whether APP helps cells respond to genomic stress. Loss of APP led to the buildup of nuclear-derived waste, abnormal nuclear morphology, inflammation, and cell death, while APP overexpression reduced these effects. Mechanistically, APP supported lysosomal exocytosis, enabling cells to release harmful nuclear debris. Familial AD-associated APP mutations failed to perform this protective clearance function. Human AD brain tissue also showed accumulation of cytoplasmic nuclear waste and lower APP levels per neuron. APP dysfunction may contribute to neurodegeneration not only through amyloid-β production, but also by impairing nuclear waste clearance and cellular cleanup.

Visit us at https://treventis.com/


https://www.pnas.org/doi/10.1073/pnas.2524190123